In conclusion, this study explored the therapeutic potential of SFN for NEC and demonstrated that SFN may inhibit the inflammatory response and apoptosis by activating the PI3K/AKt/GSK-3β pathway to protect against intestinal injury induced by NEC. The gene discussed is GSK3B; the disease is necrotizing enterocolitis.